📅 PUBMED DAILY TRIAGE — 2026-11-05 Window: 2026-11-04T00:00:00Z → 2026-11-05T10:00:03Z (CRDT) Topics scanned: 9 | Articles reviewed (EFetch): 137 | Candidates evaluated: 137 High priority: 2 | Standard: 24 | Low/archive: 59 | Unsolicited finds: 2 Run status: SUCCESS (ESearch CRDT filter unavailable; direct PMID-range scan used)
🔴🟠 HIGH PRIORITY (8+) — Best Finds by Topic
Hematologic malignancies (AML, MDS, CLL, MPN, lymphoma)
No high-priority finds today (best candidate scored 6/10)
CBC-based diagnostics and machine learning in hematology
No high-priority finds today (best candidate scored 0/10)
Early cancer detection (liquid biopsy, ctDNA, cfDNA)
No high-priority finds today (best candidate scored 6/10)
AI/ML in clinical diagnostics and imaging
PMID 42978651 · Artificial intelligence-driven imaging-based prediction models for hemorrhagic t · 8/10 Why it matters: AI-driven imaging-based prediction models demonstrated generally favorable discrimination performance in predicting hemo
Precision oncology and genomic medicine
No high-priority finds today (best candidate scored 0/10)
Novel therapeutics: immunotherapy, CAR-T, targeted therapy
PMID 42978956 · Discordance of PD-L1 expression between primary and paired metastatic non-small · 8/10 Why it matters: PD-L1 expression shows significant discordance between primary and paired metastatic NSCLC tumors, with 1,029 matched sa
Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk
No high-priority finds today (best candidate scored 7/10)
Aging, longevity, and population health
No high-priority finds today (best candidate scored 6/10)
Rare diseases with high unmet need
No high-priority finds today (best candidate scored 5/10)
🟢⚪ STANDARD (4-7) — Top by Topic
Hematologic malignancies (AML, MDS, CLL, MPN, lymphoma)
PMID 42978686 · The relationship of homocysteine and its redox forms with renal toxicity after h · 6/10 · Treatment Innovation PMID 42978806 · Intrathyroidal Relapse of Multiple Myeloma Mimicking Primary Thyroid Neoplasia: · 4/10 · Treatment Innovation
Early cancer detection (liquid biopsy, ctDNA, cfDNA)
PMID 42981216 · Development of a multi-payer cohort for comprehensive statewide small area estim · 6/10 · Early Detection PMID 42978105 · Plasma IFNL3 for Gastric Cancer Detection and Monitoring in East Asians: A Multi · 5/10 · Early Detection
AI/ML in clinical diagnostics and imaging
PMID 42978722 · Domain-specific associations of metabolomic features with cognition and neural n · 5/10 · Diagnostics
Novel therapeutics: immunotherapy, CAR-T, targeted therapy
PMID 42978095 · Cost-effectiveness analysis of dostarlimab plus chemotherapy versus chemotherapy · 7/10 · Treatment Innovation PMID 42978949 · Efficacy comparison of neoadjuvant chemotherapy, chemoradiotherapy, and chemoimm · 6/10 · Treatment Innovation PMID 42978995 · The evolution of antigen specific cancer immunotherapy from adoptive cell therap · 6/10 · Treatment Innovation PMID 42978598 · Durable Complete Response to Pembrolizumab for Postoperative Nodal Recurrence of · 4/10 · Treatment Innovation PMID 42978655 · Case Report: SMARCA4-deficient uterine sarcoma with exceptional response to immu · 4/10 · Treatment Innovation
Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk
PMID 42978240 · Cardiometabolic, Physiological and Objective-Sleep Responses to Transcendental M · 7/10 · Treatment Innovation PMID 42978566 · Real-world safety profile of finerenone in patients with type 2 diabetes and chr · 6/10 · Treatment Innovation PMID 42978123 · EXPRESS: Age, Insurance, and Social Vulnerability as Determinants of Sodium-Gluc · 5/10 · Treatment Innovation PMID 42978296 · Longitudinal Mean HbA1c and Electrodiagnostic Severity of Distal Symmetric Senso · 5/10 · Treatment Innovation PMID 42978613 · Changing diagnostic criteria and their impact on metabolic syndrome: a systemati · 4/10 · Treatment Innovation
Aging, longevity, and population health
PMID 42978121 · EXPRESS: Effect of Dexmedetomidine on Postoperative Cognitive Dysfunction in Eld · 6/10 · Public Health PMID 42978349 · Embedding person-centered nutrition assessment and care in Korea's Community Int · 4/10 · Public Health PMID 42978350 · Nutrition education programs for community-dwelling older adults in Korea: a sco · 4/10 · Public Health PMID 42978352 · Changes in hygiene management performance across monitoring visit rounds in long · 4/10 · Public Health PMID 42978354 · Comparison of health, functional, and dietary characteristics between low-income · 4/10 · Public Health
Rare diseases with high unmet need
PMID 42978157 · Reliability and accuracy of smartphone-based facial scanning: Validation with di · 5/10 · Drug Development PMID 42978193 · Management and outcomes of small U3-U4 thyroid nodules: do sub-centimetre U3 nod · 5/10 · Drug Development PMID 42978409 · Small neuroendocrine proliferations in columnar mucosa at or near the gastroesop · 5/10 · Drug Development
💡 UNSOLICITED FINDS
PMID 42978241 · Compliance with French Military Health Service guidelines for prehospital transf · 5/10 Why it matters: A prospective evaluation of our findings is needed before proposing a revision to the current FHS guideline, including t
PMID 42978152 · A multi-guideline clinical agent for vascular surgery: architecture, implementat · 4/10 Why it matters: These results support the feasibility of a multi-guideline context-aware clinical agent for vascular surgery; citation t
📊 TODAY'S BREAKDOWN
By research category:
- Treatment Innovation: 14
- Public Health: 5
- Drug Development: 3
- Diagnostics: 2
- Early Detection: 2
- Other: 2
By evidence maturity:
- Exploratory: 4
- Validated: 24
By watchlist topic:
- Hematologic malignancies (AML, MDS, CLL, MPN, lymphoma): 15 reviewed / 2 kept / highest score 6
- CBC-based diagnostics and machine learning in hematology: 15 reviewed / 0 kept / highest score 0
- Early cancer detection (liquid biopsy, ctDNA, cfDNA): 15 reviewed / 2 kept / highest score 6
- AI/ML in clinical diagnostics and imaging: 15 reviewed / 2 kept / highest score 8
- Precision oncology and genomic medicine: 15 reviewed / 0 kept / highest score 0
- Novel therapeutics: immunotherapy, CAR-T, targeted therapy: 15 reviewed / 7 kept / highest score 8
- Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk: 15 reviewed / 5 kept / highest score 7
- Aging, longevity, and population health: 15 reviewed / 5 kept / highest score 6
- Rare diseases with high unmet need: 15 reviewed / 3 kept / highest score 5
By source type: peer_reviewed 28 | preprint 0
Topics with zero 8+ articles this run: Hematologic malignancies, CBC-based diagnostics and machine learning in hematology, Early cancer detection, Precision oncology and genomic medicine, Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk, Aging, longevity, and population health, Rare diseases with high unmet need
🔧 RUN NOTES
- ESearch CRDT filter failure: NCBI ESearch returned HTTP 500 for all queries using the 2026-11-04→2026-11-05 CRDT date range (both embedded-term format and separate datetype/mindate/maxdate parameter format). No ESearch fallback produced results.
- Fallback: direct PMID-range scan. ESummary confirmed PMID range 42978000–42982800 covers CRDT 2026-11-03 23:30 → 2026-11-04 22:53. Total Nov 4 articles found: 4,719. Title-based keyword scan selected 15 candidates per watchlist topic and 10 for sentinel scan.
- Coverage: All 137 unique candidate PMIDs retrieved via ESummary (0 missing) and EFetch text mode (0 missing). Full per-topic coverage achieved.
- window_start expanded to 2026-11-04T00:00:00Z (full calendar day) per CRDT calendar-day boundary rule; previous run window ended at 2026-11-04T10:22:30Z.
- CBC/ML topic: Previous run also returned 0 raw results. No CBC+ML articles found in CRDT window today; 15 candidates selected via title scan but none passed false-positive validation after abstract review.
- web_fetch tool limitation: web_fetch tool returned HTTP 500 for all NCBI E-utilities URLs due to URL encoding incompatibility with the tool's proxy layer. Python urllib used for retrieval per skill fallback rules.